Atlas Trials

Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder

Clinical trial NCT01903200 · COMPLETED

Trial details

NCT number
NCT01903200
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Major Depressive Disorder Patients
Start date
2010-02-01
Primary completion
2011-09-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.